AboutSign In

Lenacapavir

Product

First-in-class long-acting HIV capsid inhibitor marketed as Sunlenca by Gilead Sciences

1 story

01
health3h ago

Single Infusion Treatment Shows Potential to Suppress HIV for Years

12 min read